As sales climb, Jazz's Epidiolex falls short in Japanese study in treatment-resistant epilepsies

As sales climb, Jazz's Epidiolex falls short in Japanese study in treatment-resistant epilepsies fkansteiner Fri, 08/23/2024 - 10:07